We’re excited to announce our partnership with Morgan Health, Nexus NeuroTech Ventures, and existing investor AIF. Collectively, these investments will allow us to expand access to high-quality care for families and bring us closer to our goal of making whole-child, whole-family, value-based care the national standard for autism and other neurodevelopmental differences. Our investment partners recognize that caregivers face a complex, fragmented journey for diagnosis and care for autism, ADHD, and other neurodevelopmental conditions. They share our belief that whole-child, value-based contracts accelerate families’ access to evaluations, diagnoses, and personalized care, while removing family stressors and barriers to therapy. Our partners also share our vision for bringing precision medicine and scientifically validated technology to neurodevelopmental care to drive better, faster outcomes. Together, we’re committed to providing comprehensive, evidence-based support for families and optimizing treatment pathways based on each child’s evolving clinical profile. ? We thank our investor partners for the important role they are playing in developing effective and scalable care solutions, transforming care delivery, and enhancing outcomes for children and families nationwide.
Newsflash! ?? As the prevalence of autism and other developmental disabilities continues to grow, so does the demand for innovative solutions within employer-sponsored health care. This investment in Cortica - the nation’s leading service provider for autistic and neurodivergent children - builds on our commitment to testing and scaling solutions that help employees and their families better navigate their care. With 24 clinics across 8 states, Cortica provides access to integrated medical and behavioral care. https://spr.ly/6042shb0a